Smart cap could help glaucoma patients never miss an eye drop again
NCT ID NCT07664943
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a smart cap called iD2 that fits on eye drop bottles. It tracks when you remove the cap and sends reminders to your phone if you forget a dose. The goal is to help people with glaucoma take their drops more regularly, which can prevent vision loss. About 100 adults who have trouble remembering their drops will try the device for a few weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
iD2 smart eye drop cap monitor (device)
What this could lead to
If it works, this device could help glaucoma patients stick to their eye drop schedule, potentially preserving vision and quality of life.
What could go wrong
This is a small, early-stage study with no blinding or control group. The device only tracks cap removal, not actual drop delivery, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••